General MedicationsORAL, RECTALStandard
SODIUM POLYSTYRENE SULFONATE
SODIUM POLYSTYRENE SULFONATE
Standard Dose
15GM/60ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview SODIUM POLYSTYRENE SULFONATE is listed in Drugs@FDA under application 214912 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient SODIUM POLYSTYRENE SULFONATE Form and strength SUSPENSION;ORAL, RECTAL - 15GM/60ML Sponsor LYNE Submission history Latest submission status date: 2025-06-10 00:00:00.
Structured Monograph
Clinical summary
Approval overview SODIUM POLYSTYRENE SULFONATE is listed in Drugs@FDA under application 214912 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient SODIUM POLYSTYRENE SULFONATE Form and strength SUSPENSION;ORAL, RECTAL - 15GM/60ML Sponsor LYNE Submission history Latest submission status date: 2025-06-10 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.